DAFNA Capital Management as of June 30, 2017
Portfolio Holdings for DAFNA Capital Management
DAFNA Capital Management holds 75 positions in its portfolio as reported in the June 2017 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Loxo Oncology | 17.4 | $24M | 304k | 80.19 | |
AtriCure (ATRC) | 6.7 | $9.3M | 384k | 24.25 | |
Immunomedics | 4.0 | $5.6M | 638k | 8.83 | |
Aerie Pharmaceuticals | 4.0 | $5.6M | 107k | 52.55 | |
NxStage Medical | 3.9 | $5.4M | 216k | 25.07 | |
Blueprint Medicines (BPMC) | 3.0 | $4.2M | 82k | 50.67 | |
BioCryst Pharmaceuticals (BCRX) | 2.4 | $3.3M | 591k | 5.56 | |
Beigene (BGNE) | 2.4 | $3.3M | 73k | 45.01 | |
Insulet Corporation (PODD) | 2.3 | $3.3M | 64k | 51.30 | |
Galapagos Nv- (GLPG) | 2.1 | $3.0M | 39k | 76.51 | |
Insulet Corp note 2.000% 6/1 | 2.0 | $2.7M | 2.3M | 1.22 | |
iShares NASDAQ Biotechnology Index (IBB) | 1.9 | $2.7M | 8.7k | 310.11 | |
Alder Biopharmaceuticals | 1.8 | $2.5M | 221k | 11.45 | |
Neurocrine Biosciences (NBIX) | 1.8 | $2.5M | 55k | 45.99 | |
Biotelemetry | 1.8 | $2.5M | 75k | 33.45 | |
Minerva Neurosciences | 1.8 | $2.4M | 276k | 8.85 | |
Radius Health | 1.7 | $2.4M | 53k | 45.23 | |
Sunesis Pharmaceuticals Inc Ne | 1.6 | $2.3M | 850k | 2.70 | |
Dermira | 1.6 | $2.2M | 76k | 29.14 | |
Spectranetics Corporation | 1.5 | $2.1M | 56k | 38.39 | |
Applied Genetic Technol Corp C | 1.5 | $2.1M | 421k | 5.10 | |
Macrogenics (MGNX) | 1.5 | $2.1M | 119k | 17.51 | |
Sangamo Biosciences (SGMO) | 1.4 | $2.0M | 225k | 8.80 | |
Cellectis S A (CLLS) | 1.4 | $2.0M | 76k | 25.82 | |
Akebia Therapeutics (AKBA) | 1.4 | $2.0M | 136k | 14.37 | |
Protalix Biotherapeutics Inc note 4.500% 9/1 | 1.4 | $1.9M | 2.5M | 0.77 | |
Ardelyx (ARDX) | 1.4 | $1.9M | 373k | 5.10 | |
Voyager Therapeutics (VYGR) | 1.3 | $1.8M | 205k | 8.96 | |
Dermira Inc note 3.000% 5/1 | 1.2 | $1.7M | 1.5M | 1.11 | |
Foamix Pharmaceuticals | 1.2 | $1.7M | 356k | 4.64 | |
Advaxis | 1.1 | $1.6M | 247k | 6.49 | |
Cidara Therapeutics Inc Common Stock Usd 0.0001 | 1.1 | $1.6M | 209k | 7.50 | |
Neos Therapeutics | 1.1 | $1.5M | 210k | 7.30 | |
Aeglea Biotherapeutics | 1.0 | $1.3M | 350k | 3.85 | |
Uniqure Nv (QURE) | 0.9 | $1.3M | 204k | 6.19 | |
Johnson & Johnson (JNJ) | 0.9 | $1.2M | 9.4k | 132.34 | |
Achillion Pharmaceuticals | 0.9 | $1.2M | 267k | 4.59 | |
Rigel Pharmaceuticals | 0.9 | $1.2M | 444k | 2.73 | |
Xenon Pharmaceuticals (XENE) | 0.8 | $1.2M | 378k | 3.15 | |
Neuroderm Ltd F | 0.8 | $1.1M | 38k | 29.89 | |
ArQule | 0.7 | $973k | 785k | 1.24 | |
Syneron Medical Ltd ord | 0.7 | $941k | 86k | 10.95 | |
Ascendis Pharma A S (ASND) | 0.7 | $922k | 33k | 27.76 | |
Scynexis | 0.7 | $907k | 507k | 1.79 | |
Argenx Se (ARGX) | 0.6 | $848k | 40k | 21.20 | |
Bluebird Bio (BLUE) | 0.6 | $840k | 8.0k | 105.00 | |
Biolinerx Ltd-spons | 0.6 | $824k | 980k | 0.84 | |
Zogenix | 0.6 | $809k | 56k | 14.50 | |
Stereotaxis (STXS) | 0.6 | $796k | 1.4M | 0.58 | |
Ironwood Pharmaceuticals Inc dbcv 2.250% 6/1 | 0.6 | $768k | 573k | 1.34 | |
Exactech | 0.5 | $689k | 23k | 29.78 | |
Cogentix Medical | 0.4 | $615k | 354k | 1.74 | |
Tandem Diabetes Care | 0.4 | $579k | 724k | 0.80 | |
Inotek Pharmaceuticals | 0.3 | $451k | 237k | 1.90 | |
Cascadian Therapeutics | 0.3 | $436k | 117k | 3.72 | |
Masimo Corporation (MASI) | 0.3 | $388k | 4.3k | 91.29 | |
Gemphire Therapeutics | 0.3 | $394k | 31k | 12.79 | |
Inotek Pharmaceuticals 5.75% Cb 08/01/2021-registe bond | 0.3 | $372k | 600k | 0.62 | |
Sierra Oncology | 0.2 | $310k | 265k | 1.17 | |
Natus Medical | 0.2 | $295k | 7.9k | 37.34 | |
Conatus Pharmaceuticals | 0.2 | $288k | 50k | 5.76 | |
Eiger Biopharmaceuticals | 0.2 | $284k | 36k | 7.89 | |
Arena Pharmaceuticals | 0.2 | $262k | 16k | 16.85 | |
Dexcom Inc dbcv 0.750% 5/1 | 0.2 | $255k | 250k | 1.02 | |
Bellicum Pharma | 0.2 | $234k | 20k | 11.70 | |
Spring Bk Pharmaceuticals In | 0.1 | $217k | 1.6k | 135.62 | |
Obseva Sa | 0.1 | $214k | 25k | 8.56 | |
Affimed Therapeutics B V | 0.1 | $190k | 93k | 2.05 | |
Edge Therapeutics | 0.1 | $199k | 19k | 10.26 | |
Array BioPharma | 0.1 | $167k | 20k | 8.35 | |
Adamis Pharmaceuticals Corp Com Stk | 0.1 | $127k | 24k | 5.20 | |
Anaptysbio Inc Common (ANAB) | 0.1 | $132k | 5.5k | 24.00 | |
Cymabay Therapeutics | 0.1 | $110k | 19k | 5.77 | |
Trillium Therapeutics, Inc. Cmn | 0.1 | $88k | 20k | 4.40 | |
Galena Biopharma | 0.0 | $27k | 46k | 0.59 |